Hope for pancreatic cancer urine test
3 August 2015 | By Victoria White
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers have found...
List view / Grid view
News
Positive top-line results for Phase 3 telotristat etiprate study
3 August 2015 | By Victoria White
A Phase 3 clinical trial met its primary endpoint, showing the benefit of oral telotristat etiprate in treating cancer patients with carcinoid syndrome...
World’s first international pharmaceutical seminar on Transmission Raman Spectroscopy
31 July 2015 | By Cobalt Light System
Cobalt is hosting the first ever seminar on the use of Transmission Raman Spectroscopy (TRS) in quantitative pharmaceutical analysis...
Antibiotic resistance poorly communicated and widely misunderstood
31 July 2015 | By Victoria White
People in the UK have little awareness of what ‘antibiotic resistance’ means, according to new research commissioned by the Wellcome Trust...
Ebola vaccine found to have 100% efficacy in a Phase 3 trial
31 July 2015 | By Victoria White
Merck said today that its Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100% efficacy in an analysis of interim data from a Phase 3 ring trial...
Eisai and Halozyme to investigate Halaven and PEGPH20 in metastatic breast cancer
31 July 2015 | By Victoria White
Eisai and Halozyme are to collaborate to evaluate Halaven in combination with PEGPH20 in first line HER2-negative metastatic breast cancer...
Roche submits filing to FDA for Cobas EGFR Mutation Test v2
31 July 2015 | By Victoria White
Roche submitted the cobas EGFR Mutation Test v2 for Premarket Approval (PMA) to the FDA, as a companion diagnostic test for AZD9291...
Eisai submits regulatory applications for eribulin in the US, EU and Japan
31 July 2015 | By Victoria White
Eisai has submitted regulatory applications in the US, EU and Japan for eribulin for the treatment of patients with inoperable soft tissue sarcoma (STS)...
Perjeta regimen approved in EU for early stage breast cancer
31 July 2015 | By Victoria White
The EC has approved the use of Perjeta in combination with Herceptin and chemotherapy for use before surgery in patients with early stage breast cancer...
Allergan confirms generic Tyvaso patent challenge
30 July 2015 | By Victoria White
Allergan has filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval to market a generic version of United Therapeutics' Tyvaso...
Astellas’ Phase 3 isavuconazole study fails to meet endpoint
30 July 2015 | By Victoria White
Astellas has announced that a Phase 3 study evaluating the efficacy and safety of isavuconazole in candidemia did not meet its primary endpoint...
Positive top-line results for Ascendis Pharma’s TransCon Growth Hormone
30 July 2015 | By Victoria White
Ascendis Pharma has announced positive top-line results from a study evaluating the safety and efficacy of TransCon Growth Hormone in children with GHD...
Cherwell launches refreshed website for Cleanroom Microbiology Solutions
30 July 2015 | By Cherwell Laboratories
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, have announced the launch of a refreshed website....
Phase 1/2 trial of Mogamulizumab and Opdivo in advanced solid tumours announced
30 July 2015 | By Victoria White
Kyowa Hakko Kirin and Bristol-Myers Squibb are to conduct a Phase 1/2 combination study with mogamulizumab and Opdivo in advanced solid tumours...
CHMP grants label extension for GSK’s Synflorix
30 July 2015 | By Victoria White
CHMP has granted a label extension for Synflorix to include protection against IPD caused by pneumococcal serotype 19A in children aged 6 weeks to 5 years...
